Constitutive and Inducible Mechanisms for Synthesis and Release of Cytokines in Immune Cell Lines

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4087-4093

  Baumgartner, Rudolf A ^a,b   Deramo, Vincent A ^a   Beaven, Michael A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [1 (3 AMINOPROPYL) 3 INDOLYL] 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; BREFELDIN A; CYCLOPENTANE DERIVATIVE; DEXAMETHASONE; ENZYME INHIBITOR; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; PROTEIN KINASE C; RO 31-7549; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GOLGI COMPLEX; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTE ACTIVATION; MACROPHAGE; MACROPHAGE ACTIVATION; MAST CELL; MAST CELL LEUKEMIA; METABOLISM; PATHOLOGY; RAT; SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; BREFELDIN A; CYCLOPENTANES; DEXAMETHASONE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GOLGI APPARATUS; HUMANS; INDOLES; LEUKEMIA, BASOPHILIC, ACUTE; LYMPHOCYTE ACTIVATION; LYMPHOMA, LARGE-CELL, DIFFUSE; MACROPHAGE ACTIVATION; MACROPHAGES; MALEIMIDES; MAST CELLS; PROTEIN KINASE C; RATS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030292722     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Colten, H. R. 1994. Drawing a double-edged sword. Nature 371:474.
2. Baumgartner, R. A., and M. A. Beaven. 1996. Mediator release by mast cells and basophils. In Handbook of Experimental Immunology, 5th Ed. L. A. Herzenberg, and L. Herzenberg, eds. Blackwell Science, Cambridge, MA. In press.
3. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328:257.
4. az in a mast cell line. J. Immunol. 157:1625.
5. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
6. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
7. Pennington, D. W., A. R. Lopez, P. S. Thomas, C. Peck, and W. M. Gold. 1992. Dog mastocytoma cells produce transforming growth factor β1. J. Clin. Invest. 90:35.
8. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
9. Roberts, A. B., and M. B. Sporn. 1993. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1.
10. Baumgartner, R. A., K. Yamada, V. A. Deramo, and M. A. Beaven. 1994. Secretion of tumor necrosis factor (TNF) from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process. J. Immunol. 153:2609.
11. Rhoades, K. L., S. H. Golub, and J. S. Economou. 1992. The regulation of the human tumor necrosis factor a promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 267:22102.
12. Barsumian, E. L., C. Isersky, M. G. Petrino, and R. P. Siraganian. 1981. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur. J. Immunol. 11:317.
13. Maeyama, K., R. J. Hohman, H. Metzger, and M. A. Beaven. 1986. Quantitative relationships between aggregation of IgE receptors, generation of intracellular signals, and histamine secretion in rat basophilic leukemia (2H3) cells: enhanced responses with heavy water. J. Biol. Chem. 261:2583.
14. Yamada, K., C. L. Jelsema, and M. A. Beaven. 1992. Certain inhibitors of protein serine/threonine kinases also inhibit tyrosine-phosphorylation of phospholipase Cγ1 and other proteins and reveal distinct roles for tyrosine kinase(s) and protein kinase C in stimulated, rat basophilic RBL-2H3 cells. J. Immunol. 149:1031.
15. Beaven, M. A., D. F. Guthrie, J. P. Moore, G. A. Smith, T. R. Hesketh, and J. C. Metcalfe. 1987. Synergistic signals in the mechanism of antigen-induced exocytosis in 2H3 cells: evidence for an unidentified signal required for histamine release. J. Cell Biol. 105:1129.
16. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268:1749.
17. Wilkinson, S. E., P. J. Parker, and J. S. Nixon. 1993. Isoenzyme specificity of bisindolylroaleimides, selective inhibitors of protein kinase C. Biochem. J. 294:335.
18. Matteis, M. A. D., G. Santini, R. A. Kahn, G. D. Tullio, and A. Luini. 1993. Receptor and protein kinase C-mediated regulation of ARF binding to the Golgi complex. Nature 364:818.
19. Border, W. A., and N. A. Noble. 1994. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1286.
20. Beaven, M. A. 1978. Histamine: its role in physiological and pathological processes. Monog. Allergy 13:1.
21. Claman, H. N. 1993. Mast cells and fibrosis. Hints from graft-versus-host disease and scleroderma. In The Mast Cell in Health and Disease. M. A. Kaliner and D. D. Metcalfe, eds. Marcel Dekker, New York, p. 653.
22. Bienenstock, J., A. D. Befus, and J. A. Denburg. 1986. Mast cell heterogeniety: basic questions and clinical implications. In Mast Cell Differentiation and Heterogeniety. J. Bienenstock and J. A. Denburg, eds. Raven Press, New York, p. 391.
23. Ruscetti, F. W., and M. A. Palladino. 1991. Transforming growth factor-β and the immune system. Prog. Growth Factor Res. 3:159.
24. Wahl, S. M. 1992. Transforming growth factor β (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 12:61.
25. Meade, R., P. W. Askenase, G. P. Geba, K. Neddermann, R. O. Jacoby, and R. D. Pasternak. 1992. Transforming growth factor-β1 inhibits murine immediate and delayed type hypersensitivity. J Immunol. 149:521.
26. Pennington, D. W., S. J. Ruoss, and W. M. Gold. 1992. Dog mastocytoma cells secrete a growth factor for fibroblasts. Am. J. Respir. Cell. Mol. Biol. 6:625.
27. Gordon, J. R., and S. J. Galli. 1994. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc∈RI: role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J. Exp. Med. 180:2027.
28. Gruber, B. L., M. J. Marchese, and R. R. Kew. 1994. Transforming growth factor-β1 mediates mast cell chemotaxis. J. Immunol. 152:5860.
29. Ayanlar Batuman, O., A. P. Ferrero, A. Diaz, and S. A. Jimenez. 1991. Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88:1574.
30. Batuman, O. A., A. Ferrero, C. Cupp, S. A. Jimenez, and K. Khalili. 1995. Differential regulation of transforming growth factor β-1 gene expression by glucocorticoids in human T and glial cells. J. Immunol. 155:4397.
31. Birchall, A. M., J. Bishop, D. Bradshaw, A. Cline, J. Coffey, L. H. Elliott, V. M. Gibson, A. Greenham, T. J. Hallam, W. Harris, C. H. Hill, A. Hutchings, A. G. Lamont, G. Lawton, E. J. Lewis, A. Maw, J. S. Nixon, D. Pole, J. Wadsworth, and S. E. Wilkinson. 1994. Ro32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol. Exp. Ther. 268:922.